These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37245083)

  • 1. TRIM13 inhibits cell proliferation and induces autophagy in lung adenocarcinoma by regulating KEAP1/NRF2 pathway.
    Yu B; Zhou Y; He J
    Cell Cycle; 2023 Jun; 22(12):1496-1513. PubMed ID: 37245083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM13 inhibited cell proliferation and induced cell apoptosis by regulating NF-κB pathway in non-small-cell lung carcinoma cells.
    Xu L; Wu Q; Zhou X; Wu Q; Fang M
    Gene; 2019 Oct; 715():144015. PubMed ID: 31357025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway.
    Liang M; Wang L; Sun Z; Chen X; Wang H; Qin L; Zhao W; Geng B
    Cell Commun Signal; 2022 May; 20(1):62. PubMed ID: 35534896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild Oxidative Stress Reduces NRF2 SUMOylation to Promote
    Xu J; Guo H; Xing Z; Zhang W; He J; Cheng J; Cai R
    Oxid Med Cell Longev; 2020; 2020():6240125. PubMed ID: 33299528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
    Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
    Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
    Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
    Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression.
    Zhang Z; Chen Q; Huang C; Rao D; Sang C; Zhu S; Gu L; Xie C; Tang Z; Xu X
    Mol Carcinog; 2022 Dec; 61(12):1161-1176. PubMed ID: 36193777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative Regulation of the Keap1-Nrf2 Pathway by a p62/Sqstm1 Splicing Variant.
    Kageyama S; Saito T; Obata M; Koide RH; Ichimura Y; Komatsu M
    Mol Cell Biol; 2018 Apr; 38(7):. PubMed ID: 29339380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the p62-Keap1-Nrf2 pathway improves pulmonary arterial hypertension in MCT-induced rats by inhibiting autophagy.
    Jiang G; Shi LF; Li LJ; Duan XJ; Zheng ZF
    FASEB J; 2024 Feb; 38(3):e23452. PubMed ID: 38308640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62.
    Lau A; Wang XJ; Zhao F; Villeneuve NF; Wu T; Jiang T; Sun Z; White E; Zhang DD
    Mol Cell Biol; 2010 Jul; 30(13):3275-85. PubMed ID: 20421418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation.
    Sun C; Han B; Zhai Y; Zhao H; Li X; Qian J; Hao X; Liu Q; Shen J; Kai G
    Free Radic Biol Med; 2022 Feb; 180():220-235. PubMed ID: 35074488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p62 promotes bladder cancer cell growth by activating KEAP1/NRF2-dependent antioxidative response.
    Li T; Jiang D; Wu K
    Cancer Sci; 2020 Apr; 111(4):1156-1164. PubMed ID: 31967368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM16 controls assembly and degradation of protein aggregates by modulating the p62-NRF2 axis and autophagy.
    Jena KK; Kolapalli SP; Mehto S; Nath P; Das B; Sahoo PK; Ahad A; Syed GH; Raghav SK; Senapati S; Chauhan S; Chauhan S
    EMBO J; 2018 Sep; 37(18):. PubMed ID: 30143514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
    Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
    Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analyses reveal the contribution of somatic variants to the immune landscape of multiple cancer types.
    Bi W; Xu Z; Liu F; Xie Z; Liu H; Zhu X; Zhong W; Zhang P; Tang X
    PLoS Genet; 2024 Jan; 20(1):e1011134. PubMed ID: 38241355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox
    Wei XW; Lu C; Zhang YC; Fan X; Xu CR; Chen ZH; Wang F; Yang XR; Deng JY; Yang MY; Gou Q; Mei SQ; Luo WC; Zhong RW; Zhong WZ; Yang JJ; Zhang XC; Tu HY; Wu YL; Zhou Q
    Oncoimmunology; 2024; 13(1):2340154. PubMed ID: 38601319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
    Singh A; Misra V; Thimmulappa RK; Lee H; Ames S; Hoque MO; Herman JG; Baylin SB; Sidransky D; Gabrielson E; Brock MV; Biswal S
    PLoS Med; 2006 Oct; 3(10):e420. PubMed ID: 17020408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma.
    Yuan G; Hu B; Ma J; Zhang C; Xie H; Wei T; Yang Y; Ni B
    Cancer Med; 2023 Mar; 12(6):7258-7272. PubMed ID: 36504353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.